Skin bleaching with the use of glutathione is on the rise, despite the potential ethical issues and adverse side effects associated with the practice, warns a doctor in The BMJ this week.
Aug 31, 2016
0
0
Several scientific studies have indicated that nicotine may be beneficial for memory function. Scientists from the Institut Pasteur and the CNRS set out to shed further light on the properties attributed to nicotine - which ...
Aug 29, 2016
0
3
Researchers have used a non-invasive method of observing how the process leading to Parkinson's disease takes place at the nanoscale, and identified the point in the process at which proteins in the brain become toxic, eventually ...
Mar 14, 2016
0
256
(HealthDay)—Further investigation of the addition of amphotericin B to Optisol-GS, the most commonly used corneal storage medium in the United States, is warranted, according to research published online Feb. 25 in JAMA ...
Feb 29, 2016
0
2
Guilt-free sugary treats may be on the horizon. Scientists at the University of Montreal Hospital Research Centre (CRCHUM) have discovered an enzyme that can stop the toxic effects of sugar in various organs of the body. ...
Jan 11, 2016
2
165
Electronic cigarettes produce highly-reactive free radicals—molecules associated with cell damage and cancer—and may pose a health risk to users, according to researchers at Penn State College of Medicine.
Dec 3, 2015
1
27
(HealthDay)—Naturally occurring monoclonal antibodies show potential for treatment of neurologic diseases, according to a review published online Sept. 21 in JAMA Neurology.
Sep 22, 2015
0
10
JAMA Oncology will publish two studies, a commentary and an author audio interview examining outcomes in women with breast cancer who had breast-conserving surgery and were treated with hypofractionated radiation therapy ...
Aug 6, 2015
0
15
Patients who relapse in their battle with acute myeloid leukemia (AML) may benefit from a phase three study of therapies that combine an existing agent, cytarabine, with a newer compound, vosaroxin.
Dec 7, 2014
0
1
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
Oct 13, 2014
2
0
